Bicarbonate buffered ultrafiltration leads to a physiologic priming solution in pediatric cardiac surgery

Interact Cardiovasc Thorac Surg. 2008 Dec;7(6):969-72. doi: 10.1510/icvts.2008.179333. Epub 2008 Aug 21.

Abstract

Pediatric cardiopulmonary bypass (CPB) involves a high ratio of priming blood volume to patient blood volume. The composition of packed red blood cells (RBCs) is very unphysiological in terms of acid-base, electrolyte and metabolite values. Therefore, we tested the hypothesis whether ultrafiltration of the prime and replacement with bicarbonate buffered hemofiltration solution (BB-HS) is sufficient for reducing the metabolic load and reaching a physiologic state. For planned surgery of congenital heart defects with cardiopulmonary bypass, 20 CPB circuits were primed with BB-HS, gelatin and 1 unit of RBCs. The fluid was hemofiltrated using an ultrahemofilter at 300 ml/min until approximately 1000 ml of ultrafiltrate was restored with BB-HS. Blood gas analyses were obtained from the priming blood, once before and once after bicarbonate buffered ultrafiltration (BBUF). The measured substrates decreased significantly (P<0.001) after BBUF (glucose from 13.0+/-2.6 to 6.3+/-1.0 and lactate from 3.8+/-1.5 to 2.3+/-1.0 mmol/l). Acid-base parameters increased (P<0.001) to normal or high normal values (pH from 7.01+/-0.09 to 7.68+/-0.12; HCO(3) from 12.1+/-2.4 to 25.4+/-3.6 mmol/l and BE from -15.4+/-3.6 to -0.8+/-3.7 mmol/l). Even the electrolytes sodium, potassium and calcium changed significantly (P<0.001) toward the physiologic range. BBUF is an efficient method of reducing the metabolic load of priming. After BBUF, even the electrolyte and acid-base balance reached a physiologic state, which is important for minimizing electrolyte and acid-base disturbances after initiation of CPB.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acid-Base Equilibrium / drug effects
  • Acid-Base Imbalance / etiology
  • Acid-Base Imbalance / metabolism
  • Acid-Base Imbalance / prevention & control*
  • Bicarbonates / administration & dosage*
  • Buffers
  • Cardiac Surgical Procedures*
  • Cardioplegic Solutions / administration & dosage*
  • Cardiopulmonary Bypass* / adverse effects
  • Electrolytes / blood
  • Heart Defects, Congenital / metabolism
  • Heart Defects, Congenital / surgery*
  • Hemofiltration*
  • Humans
  • Infant
  • Infant, Newborn
  • Prospective Studies
  • Treatment Outcome

Substances

  • Bicarbonates
  • Buffers
  • Cardioplegic Solutions
  • Electrolytes